Public Employees Retirement Association of Colorado reduced its position in Alkermes PLC (NASDAQ:ALKS) by 3.3% during the third quarter, according to its most recent filing with the SEC. The firm owned 32,878 shares of the company’s stock after selling 1,139 shares during the period. Public Employees Retirement Association of Colorado’s holdings in Alkermes PLC were worth $1,546,000 at the end of the most recent quarter.

Other institutional investors have also recently made changes to their positions in the company. Mn Services Vermogensbeheer B.V. boosted its position in Alkermes PLC by 3.4% in the second quarter. Mn Services Vermogensbeheer B.V. now owns 3,829 shares of the company’s stock valued at $149,000 after buying an additional 127 shares in the last quarter. Evercore Wealth Management LLC boosted its position in Alkermes PLC by 1.2% in the second quarter. Evercore Wealth Management LLC now owns 14,366 shares of the company’s stock valued at $621,000 after buying an additional 166 shares in the last quarter. IBM Retirement Fund boosted its position in Alkermes PLC by 1.2% in the second quarter. IBM Retirement Fund now owns 15,193 shares of the company’s stock valued at $657,000 after buying an additional 177 shares in the last quarter. Sumitomo Mitsui Asset Management Company LTD boosted its position in Alkermes PLC by 2.1% in the second quarter. Sumitomo Mitsui Asset Management Company LTD now owns 9,651 shares of the company’s stock valued at $417,000 after buying an additional 196 shares in the last quarter. Finally, CIBC Asset Management Inc boosted its position in Alkermes PLC by 4.4% in the third quarter. CIBC Asset Management Inc now owns 6,575 shares of the company’s stock valued at $309,000 after buying an additional 275 shares in the last quarter. Institutional investors own 95.97% of the company’s stock.

Institutional Ownership by Quarter for Alkermes PLC (NASDAQ:ALKS)

Alkermes PLC (NASDAQ:ALKS) traded up 0.52% on Tuesday, reaching $58.07. The company’s stock had a trading volume of 914,567 shares. The firm has a 50-day moving average of $52.71 and a 200 day moving average of $47.68. Alkermes PLC has a 12-month low of $27.14 and a 12-month high of $80.71. The company’s market capitalization is $8.82 billion.

Alkermes PLC (NASDAQ:ALKS) last issued its quarterly earnings results on Wednesday, November 2nd. The company reported ($0.09) earnings per share for the quarter, missing the consensus estimate of ($0.06) by $0.03. The business earned $180.20 million during the quarter, compared to analyst estimates of $186.39 million. Alkermes PLC had a negative return on equity of 12.75% and a negative net margin of 36.92%. Alkermes PLC’s revenue was up 18.0% compared to the same quarter last year. During the same period in the prior year, the business posted ($0.19) EPS. On average, equities research analysts anticipate that Alkermes PLC will post ($0.20) EPS for the current fiscal year.

WARNING: “Public Employees Retirement Association of Colorado Has $1,546,000 Stake in Alkermes PLC (ALKS)” was originally published by Daily Political and is the propert of of Daily Political. If you are viewing this article on another publication, it was illegally copied and republished in violation of United States & international copyright legislation. The correct version of this article can be viewed at http://www.dailypolitical.com/2016/11/29/public-employees-retirement-association-of-colorado-has-1546000-stake-in-alkermes-plc-alks.html.

ALKS has been the topic of several research analyst reports. Jefferies Group upped their target price on shares of Alkermes PLC from $62.00 to $70.00 and gave the company a “buy” rating in a research note on Friday, October 21st. Morgan Stanley raised shares of Alkermes PLC from an “underweight” rating to a “hold” rating and set a $62.00 price target for the company in a research report on Friday, October 21st. Leerink Swann assumed coverage on shares of Alkermes PLC in a research report on Tuesday, October 4th. They set an “outperform” rating and a $57.00 price target for the company. Citigroup Inc. upped their price target on shares of Alkermes PLC from $44.00 to $53.00 and gave the company a “neutral” rating in a research report on Tuesday, September 27th. Finally, Zacks Investment Research lowered shares of Alkermes PLC from a “buy” rating to a “hold” rating in a research report on Tuesday, September 27th. One research analyst has rated the stock with a sell rating, three have issued a hold rating and seven have given a buy rating to the company. Alkermes PLC currently has a consensus rating of “Buy” and a consensus target price of $61.64.

In related news, SVP David Joseph Gaffin sold 2,382 shares of Alkermes PLC stock in a transaction dated Tuesday, September 6th. The stock was sold at an average price of $45.92, for a total transaction of $109,381.44. Following the completion of the sale, the senior vice president now owns 22,816 shares of the company’s stock, valued at $1,047,710.72. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CAO Iain Michael Brown sold 29,976 shares of Alkermes PLC stock in a transaction dated Tuesday, September 6th. The stock was sold at an average price of $45.92, for a total value of $1,376,497.92. Following the sale, the chief accounting officer now directly owns 25,696 shares of the company’s stock, valued at approximately $1,179,960.32. The disclosure for this sale can be found here. 4.75% of the stock is owned by company insiders.

About Alkermes PLC

Alkermes Public Limited Company is a biopharmaceutical company. The Company is engaged in researching, developing and commercializing, both with partners and on its own, pharmaceutical products that are designed to address medical needs of patients in therapeutic areas. The Company has a portfolio of approximately 20 products and a clinical pipeline of product candidates that address central nervous system (CNS) disorders, such as schizophrenia, depression, addiction and multiple sclerosis.

5 Day Chart for NASDAQ:ALKS

Want to see what other hedge funds are holding ALKS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Alkermes PLC (NASDAQ:ALKS).

Receive News & Ratings for Alkermes PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alkermes PLC and related companies with MarketBeat.com's FREE daily email newsletter.